Mortality News and Research

RSS

Simple procedural change may reduce cardiac arrests outside pediatric ICUs

A simple procedural change may significantly reduce cardiopulmonary arrests outside a pediatric hospital's intensive care unit, according to a study reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

11 May 2007

FluForecast trial predicted high human H5N1 mortality in Indonesia

When H5N1 was thought to be quiescent in 2006, in a prospective open trial, FluForecast, a software program which measures virus gene proteins, predicted high human mortality H5N1 outbreaks to come.

10 May 2007

The influence of diluent warming on dantrolene sodium mixing time

Every second counts for anesthesia patients afflicted by the often deadly condition known as malignant hyperthermia (MH).

9 May 2007

Study compares three natural surfactants used to treat babies with respiratory distress syndrome

A pig-derived surfactant given to premature babies whose lungs aren't yet making the lubricant reduces mortality rates by 19 percent over two other commercially-available surfactants, researchers say.

8 May 2007

Surfactant replacement therapies improve neonatal survival in premature infants with neonatal respiratory distress syndrome

Data presented at the Pediatric Academic Societies, Annual Meeting demonstrate that premature infants with neonatal Respiratory Distress Syndrome (RDS) have a nearly 20% better chance of survival if they are treated with Curosurf, (poractant alfa) Intratracheal Suspension rather than either of two competing surfactant therapies.

8 May 2007

MDCT eliminates need for catheter angiography for aortic injury diagnosis

Contrast-enhanced 64-MDCT that definitively reveals acute trauma to the aorta does not need confirmation from invasive catheter angiography, which saves valuable time in treating patients in trauma centers, according to a new study by researchers from the Medical University of South Carolina in Charleston.

8 May 2007

Simple blood test for BNP levels predictive of higher in-hospital mortality rates for heart failure patients

A simple blood test, beyond standard lab tests, taken at hospital admission strongly predicted in-hospital mortality risk for heart failure patients and may be useful in helping doctors decide which patients need higher-level monitoring and more intensive treatment.

8 May 2007

Study on cerebral malaria in children living in an endemic region

Scientists at CNRS and the Pasteur Institute, collaborating with physicians in Gabon, have just undertaken a study on cerebral malaria in children living in an endemic region.

4 May 2007

Simple spit test designed to detect pre-eclampsia in the early stages

The test, which is designed to be used at home, will allow mums-to-be to check for themselves whether they are at risk of the condition, which can be symptomless in the early stages but kills 1000 babies in the UK every year.

4 May 2007

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

The U.S. Food and Drug Administration (FDA) has approved a new indication for FRAGMIN (dalteparin sodium injection), for the extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence of VTE in patients with cancer.

4 May 2007

Use of antithrombotics means more intracerebral haemorrhagic stroke deaths in over 75s

A study suggests that the number of pensioners over 75 dying from intracerebral haemorrhagic stroke has increased in the last 25 years due to use of antithrombotic drugs.

2 May 2007

Ohioans spend $62.2 billion on non-institutional health care each year

...while the Ohio economy loses between $2.1 and $5.8 billion due to lost productivity and other indirect costs of having 1.3 million Ohio residents without health insurance, according to research released today by the Health Policy Institute of Ohio (HPIO).

2 May 2007

Statin drugs also may help reduce risk of heart failure

Statin drugs, known primarily for their ability to lower cholesterol, also may reduce the overactive sympathetic nervous system response that contributes to the worsening of heart failure and increases the risk of sudden cardiac death, two University of Missouri-Columbia researchers have found. Heart failure is the leading cause of morbidity and mortality in the United States.

2 May 2007

Improving outcomes for patients with acute coronary syndrome

Recent changes in the recommended treatments used for patients hospitalized for acute coronary syndromes, such as a heart attack, are associated with reductions in the rates of heart failure, stroke, heart attack and death, according to a study in the May 2 issue of JAMA .

2 May 2007

Komen study profiles eight communities nationwide 'most affected' by breast cancer

Susan G. Komen for the Cure on Thursday released a report that profiles eight communities "most affected" by breast cancer and launched a campaign that aims to curb disparities and remove gaps in breast cancer-related care, the Washington Post reports.

1 May 2007

Adolescent risk inventory can help decrease teen risk behaviors

Research shows that adolescents who engage in one form of risky behavior, like drug or alcohol use, are likely to engage in other risky behaviors like self-harm, or having unprotected sex, but often times these behaviors are not discussed during a medical or mental health exam.

1 May 2007

Genetic risk for early death in rheumatoid arthritis

A chronic autoimmune disease, rheumatoid arthritis (RA) is marked by inflammation that takes a progressive toll on not only the joints, but also various organs and the whole body.

30 Apr 2007

Link found between bile duct obstruction and bile duct cancer

When bile duct cancer cells were placed in the liver of animals with bile duct obstruction, they grew more rapidly than identical cells placed in animals without bile duct obstruction.

30 Apr 2007

Tarceva extends life of patients with pancreatic cancer

New results published by the Journal of Clinical Oncology show that adding Tarceva (erlotinib) to gemcitabine chemotherapy significantly improves survival by 22 percent in patients with advanced pancreatic cancer.

27 Apr 2007

Ranbaxy receives approval to manufacture Pravastatin Sodium tablets in U.S.

Ranbaxy Pharmaceuticals has announced that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Pravastatin Sodium Tablets (Pravastatin), 10 mg, 20 mg, 40 mg and 80 mg, with 180-day market exclusivity in the U.S. healthcare system for the 80 mg strength.

27 Apr 2007